产品编号:C256552
产品规格:5mg
产品价格:面议
| 标准品编号: | C256552 |
| 名称: | Cenicriviroc-d9 |
| 别名: | 8-[4-(2-Butoxyethoxy)phenyl]-1,2,3,4-tetrahydro-1-(2-methylpropyl)-N-[4-[(S)-[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl]phenyl]-1-benzazocine-5-carboxamide-d9;(-)-8-[4-(2-Butoxyethoxy)phenyl]-1-isobutyl-N-[4-[[(1-propyl-1H-imidazol-5-yl)methyl]sulfinyl]phenyl]-1,2,3,4-tetrahydro-1-benzazocine-5-carboxamide-d9; TB-652-d9; Tobira-d9 |
| 参考CAS: | 497223-25-3 Unlabelled |
| 分子式: | C₄₁H₄₃D₉N₄O₄S |
| 分子量: | 706 |
| 类别: | Building Blocks; Isotopic Labeled Analogues; |
| 应用: | Cenicriviroc-d9 is labelled Cenicriviroc (C256550), an experimental drug candidate for the treatment of HIV infection. It is an inhibitor of CCR2 and CCR5 receptors, allowing it to function as an entry inhibitor which prevents the virus from entering into a human cell. |
| 参考文献 | |